Real-world outcomes in patients with hereditary angioedema prescribed lanadelumab versus other prophylaxis. Anderson J, Soteres D, Tachdjian R, Mellor J, et al. Allergy Asthma Proc 2024;45:426-433.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Anderson J, Soteres D, Tachdjian R, Mellor J, et al. Real-world outcomes in patients with hereditary angioedema prescribed lanadelumab versus other prophylaxis. Allergy Asthma Proc 2024;45:426-433.
PMID: 39293940